ACC 2011: Medtronic's Resolute DES succeeds in two trials; US approval set for 2012
This article was originally published in Clinica
Executive Summary
Two major clinical studies of Resolute, Medtronic's new-generation drug-eluting stent (DES) suggest that it may be a better therapy than the firm's Endeavor DES. Data from one of the trials will back Medtronic's US approval application for the device.